Tradestie Institutional Equity Comparison Engine
CCAP vs BCSF โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
CCAP Overall Edge
CCAP Captures Institutional Edge (2โ1 Pillars ยท 4โ6 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Crescent Capital BDC, Inc. Common stock (CCAP) driven by superior Valuation, Momentum & Technical while BCSF counters with relative strength in Growth & Margin. Fundamentally, CCAP trades at 6.9x Forward P/E with 78.4% operating margin (-15.5% YoY revenue) versus BCSF at 8.1x Forward P/E and 76.8% operating margin (-10.9% YoY). In options structure, CCAP sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against BCSF sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
CCAP
CCAP 6.9x vs BCSF 8.1x Fwd P/E
Growth & Margin Winner
BCSF
Op Margin 78.4% vs 76.8% ยท YoY -15.5% vs -10.9%
Momentum & Technical Winner
CCAP
1Y -25.8% vs -21.6% ยท 52W Pos 25% vs 19%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
CCAP
NASDAQ
Crescent Capital BDC, Inc. Common stock
Institutional Equity
$10.08
-0.49% 1D
Market Cap
$373.2M
1M Return
+13.26%
1Y Return
-25.83%
Forward P/E
6.9x
Unified AI Score
19.6 / 100
STRONG SELL
Tech 50.0
Fund 28.0
Flow 50.0
Mom 40.0
BCSF
NYSE
Bain Capital Specialty Finance, Inc.
Institutional Equity
$10.87
-1.81% 1D
Market Cap
$718.1M
1M Return
+5.95%
1Y Return
-21.63%
Forward P/E
8.1x
Unified AI Score
39.6 / 100
SELL
Tech 39.0
Fund 44.0
Flow 50.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
CCAP -25.83%
BCSF -21.63%
Spread: +4.2 pp (BCSF Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
CCAP TTM Op. Margin: 78.4%
BCSF TTM Op. Margin: 76.8%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CCAP vs BCSF. Trailing 12-month operating profitability (CCAP 78.4% vs BCSF 76.8%) and valuation multiples (CCAP 6.9x vs BCSF 8.1x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | CCAP | BCSF | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $373.2M | $718.1M | Larger Scale | BCSF |
| Trailing P/E Ratio Valuation | 7.4x | 11.5x | Lower Multiple | CCAP |
| Forward P/E Ratio Valuation | 6.9x | 8.1x | Lower Multiple | CCAP |
| Revenue Growth (YoY) Growth | -15.5% | -10.9% | Higher Growth | BCSF |
| Operating Margin (TTM) Profitability | 78.4% | 76.8% | Higher Margin | CCAP |
| Net Profit Margin Profitability | -2.0% | 24.1% | Higher Margin | BCSF |
| Return on Equity (ROE) Capital Efficiency | -0.5% | 5.6% | Higher ROE | BCSF |
| 52-Week Range Position Momentum | 25% ($8โ$15) | 19% ($10โ$15) | Stronger Trend | CCAP |
| Beta / 30D Volatility Risk Regime | 0.44ฮฒ ยท 50% Vol | 0.49ฮฒ ยท 27% Vol | Lower Realized Risk | BCSF |
| Unified Institutional Score Composite Signal | 19.6 / 100 (STRONG SELL) | 39.6 / 100 (SELL) | Higher Composite | BCSF |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full CCAP vs BCSF Buy Guide
CCAP
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
BCSF
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither CCAP nor BCSF registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.